Damjanović Aleksandar, Pantović Maja, Damjanović Aleksandra, Dunjić-Kostić Bojana, Ivković Maja, Milovanović Srđan, Lacković Maja, Dimitrijević Ivan
School of Medicine, Clinic for Psychiatry, Clinical Center of Serbia, University of Belgrade, Pasterova 2, 11000 Belgrade, Serbia.
Psychiatr Danub. 2015 Mar;27(1):97-100.
The association between cannabinoids and psychosis has been known for almost a thousand years, but it is still speculated whether cannabis use may be a contributory cause of psychosis, that is, whether it may precipitate schizophrenia in those at risk. In this paper, we will briefly present the data from individual longitudinal studies in the field, together with the factors that are considered important for the association of cannabis abuse and occurrence of schizophrenia and prevention opportunities in the target population. The reviewed studies clearly suggest that cannabis abuse predicts an increased risk for schizophrenia, particularly in young adults. They underline both the need to create adequate prevention measures and consequently avoid the occurrence of the disease in the young at risk. Particular attention should be additionally devoted toward encouraging the young presenting with psychotic symptoms to stop or, at the very least, reduce the frequency of cannabis abuse. The issues are undoubtedly to be addressed by the health care system in general.
大麻素与精神病之间的关联已为人所知近千年，但大麻使用是否可能是精神病的一个促成因素，即它是否会在有风险的人群中引发精神分裂症，仍存在推测。在本文中，我们将简要介绍该领域个体纵向研究的数据，以及那些被认为对大麻滥用与精神分裂症的关联以及目标人群中的预防机会很重要的因素。所审查的研究清楚地表明，大麻滥用预示着精神分裂症风险增加，尤其是在年轻人中。它们强调了制定适当预防措施的必要性，从而避免在有风险的年轻人中发生这种疾病。此外，应特别关注鼓励出现精神病症状的年轻人停止或至少减少大麻滥用的频率。这些问题无疑需要整个医疗保健系统来解决。
